BioCentury | Dec 2, 2016
Company News

Idera, Vivelix deal

...antagonist, has completed Phase I testing in healthy volunteers. Idera Pharmaceuticals Inc. (NASDAQ:IDRA), Cambridge, Mass. Vivelix Pharmaceuticals Ltd....
Items per page:
1 - 1 of 1
BioCentury | Dec 2, 2016
Company News

Idera, Vivelix deal

...antagonist, has completed Phase I testing in healthy volunteers. Idera Pharmaceuticals Inc. (NASDAQ:IDRA), Cambridge, Mass. Vivelix Pharmaceuticals Ltd....
Items per page:
1 - 1 of 1